Navidea Biopharmaceuticals

Last updated: January 29, 2024

CEO Mark Pykett
CEO Mark Pykett
Country: USA | Funding: $133.8M (+)

Website: http://www.navidea.com/

Navidea Biopharmaceuticals has established a niche in precision medicine. The company focuses on the development and commercialization of diagnostic agents and therapeutics for cancer, autoimmune diseases, dementia, and movement disorders.